Immatics Announces $125 Million Underwritten Offering
Immatics N.V. - Ordinary Shares (IMTX)
Company Research
Source: GlobeNewswire
Houston, Texas and Tuebingen, Germany, December 05, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, announced today that it has agreed to sell 12,500,000 ordinary shares at $10.00 per share in an underwritten offering. The gross proceeds from the offering, before deducting the underwriting discount and offering expenses, are expected to be $125 million. The offering is expected to close on December 8, 2025, subject to customary closing conditions. Jefferies, Leerink Partners and Cantor are acting as joint book-running managers for the offering. A registration statement relating to the securities has been filed with the U.S. Securities and Exchange Commission (the “SEC”) and was declared effective on April 3, 2025. The offering is being made only by means of a prospectus supplement and accompanying prospectus. When available, copies of the final prospectus supplement
Show less
Read more
Impact Snapshot
Event Time:
IMTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMTX alerts
High impacting Immatics N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
IMTX
News
- Biotech Immatics to raise $125M through ordinary share offering [Seeking Alpha]Seeking Alpha
- Immatics Announces $125 Million Underwritten Offering [Yahoo! Finance]Yahoo! Finance
- Immatics (NASDAQ:IMTX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.MarketBeat
- Immatics (NASDAQ:IMTX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $25.00 price target on the stock.MarketBeat
- Immatics (NASDAQ:IMTX) had its price target raised by analysts at Mizuho from $19.00 to $23.00. They now have an "outperform" rating on the stock.MarketBeat
IMTX
Earnings
- 11/17/25 - Beat
IMTX
Sec Filings
- 12/5/25 - Form 424B5
- 12/5/25 - Form 424B5
- 11/17/25 - Form 6-K
- IMTX's page on the SEC website